Quantitation of the tacrine analogue octahydroaminoacridine in human plasma by liquid chromatography-tandem mass spectrometry

被引:3
作者
Han, Jiangbin [1 ]
Jiang, Shuang [1 ]
Cui, Xiangyong [1 ]
Sun, Yantong [1 ,2 ]
Li, Guoqing [1 ]
Zhang, Jiwen [3 ]
Fawcett, J. Paul [4 ]
Gu, Jingkai [1 ]
机构
[1] Jilin Univ, Res Ctr Drug Metab, Coll Life Sci, Changchun 130021, Peoples R China
[2] Jilin Univ, Sch Pharmaceut Sci, Changchun 130021, Peoples R China
[3] Chinese Acad Sci, Shanghai Inst Mat Med, Shanghai 201203, Peoples R China
[4] Univ Otago, Sch Pharm, Dunedin, New Zealand
关键词
Octahydroaminoacridine; LC-MS/MS; Quantitation; Pharmacokinetics; Plasma; ALZHEIMERS-DISEASE;
D O I
10.1016/j.jpba.2009.03.022
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
A rapid and sensitive method based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) has been developed for the determination of octahydroaminoacridine in human plasma using tramadol as internal standard (I.S.). Sample preparation involved pH adjustment with sodium carbonate followed by solvent extraction with dichloromethane: ethyl ether (40:60, v/v). Chromatographic separation was achieved on a Venusil MP-C18 column (5 mu m, 100 mm x 4.6 mm) using acetonitrile: 10 MM ammonium acetate:formic acid (30:70:1, v/v/v) as mobile phase. Detection utilized an API 4000 system operated in the positive ion mode with multiple reaction monitoring of the analyte at m/z 203.1 -> 175.1 and of the I.S. at m/z 264.1 -> 58.0. The method was linear in the range 0.01-10ng/ml with a lower limit of quantitation of 0.01 ng/ml. Intra- and inter-day precisions measured as relative standard deviation were <3.15% and <5.01%, respectively. The method was successfully applied to a pharmacokinetic study involving oral administration of a tablet containing 4 mg octahydroaminoacricline succinate to healthy volunteers. Pharmacokinetic parameters for octahydroaminoacricline include C-max 1.19 +/- 0.53 ng/ml, T-max 0.77 +/- 0.17 h, AUC(0-t) 3.42 +/- 1.01 ng h/ml and t(1/2) 2.89 +/- 0.56 h. (C) 2009 Elsevier B.V. All rights reserved.
引用
收藏
页码:171 / 174
页数:4
相关论文
共 10 条
  • [1] HETEROGENEITY OF ADVERSE HEPATIC REACTIONS TO TETRAHYDROAMINOACRIDINE
    AMES, DJ
    BHATHAL, PS
    DAVIES, BM
    FRASER, JRE
    GIBSON, PR
    ROBERTS, S
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1990, 20 (02): : 193 - 195
  • [2] [Anonymous], 2001, GUID IND BIOAN METH
  • [3] Global prevalence of dementia: a Delphi consensus study
    Ferri, CP
    Prince, M
    Brayne, C
    Brodaty, H
    Fratiglioni, L
    Ganguli, M
    Hall, K
    Hasegawa, K
    Hendrie, H
    Huang, YQ
    Jorm, A
    Mathers, C
    Menezes, PR
    Rimmer, E
    Scazufca, M
    [J]. LANCET, 2005, 366 (9503) : 2112 - 2117
  • [4] New trends in the design of drugs against Alzheimer's disease
    Francotte, P
    Graindorge, E
    Boverie, S
    de Tullio, P
    Pirotte, B
    [J]. CURRENT MEDICINAL CHEMISTRY, 2004, 11 (13) : 1757 - 1778
  • [5] Hansen LL, 1998, J CHROMATOGR B, V712, P183
  • [6] Current concepts and future prospects for Alzheimer disease vaccines
    Heppner, FL
    Gandy, S
    McLaurin, J
    [J]. ALZHEIMER DISEASE & ASSOCIATED DISORDERS, 2004, 18 (01) : 38 - 43
  • [7] Selective and sensitive determination of bis(7)-tacrine, a high erythrocyte binding acetylcholinesterase inhibitor, in rat plasma by high-performance liquid chromatography-tandem mass spectrometry
    Li, Zhang
    Hu, Yu
    Ming, Li Wen
    Chun, Cheung Man
    Ping, Pang Yuan
    Ge, Lin
    Tao, Wang Yi
    Zhong, Zuo
    Fan, Han Yi
    [J]. BIOMEDICAL CHROMATOGRAPHY, 2008, 22 (04) : 414 - 420
  • [8] Matrix effects in quantitative pesticide analysis using liquid chromatography-mass spectrometry
    Niessen, W. M. A.
    Manini, P.
    Andreoli, R.
    [J]. MASS SPECTROMETRY REVIEWS, 2006, 25 (06) : 881 - 899
  • [9] Sweetman S.C., 2004, MARTINDALE COMPLETE
  • [10] HEPATOTOXIC EFFECTS OF TACRINE ADMINISTRATION IN PATIENTS WITH ALZHEIMERS-DISEASE
    WATKINS, PB
    ZIMMERMAN, HJ
    KNAPP, MJ
    GRACON, SI
    LEWIS, KW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (13): : 992 - 998